KVYO.NYSEKlaviyo, INC

Form 4: Klaviyo Director Susan St. Ledger Executes Stock Sale Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Director Susan St. Ledger sold 10,500 shares of Klaviyo's Series A Common Stock at $24.66 per share, executed under a pre-arranged 10b5-1 trading plan.

Summary

  • On May 16, 2024, Susan St. Ledger, a director at Klaviyo, Inc., sold 10,500 shares of Series A Common Stock at a price of $24.66 per share.
  • The sale was executed under a Rule 10b5-1 trading plan adopted on December 11, 2023.
  • Following the transaction, St. Ledger directly owns no shares of Series A Common Stock.
  • St. Ledger also holds 59,500 shares of Series B Common Stock, including 12,833 shares and 46,667 unvested restricted stock units.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction was executed under a pre-planned 10b5-1 trading plan, indicating a routine sale rather than a reaction to company performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders (officers, directors, or those holding more than 10% of a company's shares) buy or sell the company's stock. These filings provide transparency to the market regarding insider transactions.

Comparison to Industry Standards

  • Monitoring insider transactions is a common practice in financial analysis to gauge sentiment and potential future performance.
  • Comparing Klaviyo's insider trading activity to peers like Braze or Salesforce can provide insights into management's confidence and strategic direction.
  • Rule 10b5-1 plans are frequently used by corporate insiders to diversify their holdings while avoiding accusations of trading on non-public information, aligning with standard practices in corporate governance.

Stakeholder Impact

  • The sale of shares by a director could be perceived neutrally by shareholders, given it was executed under a pre-arranged trading plan.
  • The transaction has minimal direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
December 11, 2023Date the Reporting Person adopted the Rule 10b5-1 trading plan
May 15, 2024Date of transaction involving Series B Common Stock
May 16, 2024Date of transaction involving Series A Common Stock
May 17, 2024Date of signature for the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.